Furthermore, immunohistochemistry staining analysis indicated that there were more CD8+ T cells in the tumor sections of the NKG2DIL7-CAR treatment group (Figure 6e), all of which were consistent with the results in vitro. Here, CD8A is linked to neoplasm.